1. Home
  2. RPRX vs LAMR Comparison

RPRX vs LAMR Comparison

Compare RPRX & LAMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • LAMR
  • Stock Information
  • Founded
  • RPRX 1996
  • LAMR 1902
  • Country
  • RPRX United States
  • LAMR United States
  • Employees
  • RPRX N/A
  • LAMR N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • LAMR Real Estate Investment Trusts
  • Sector
  • RPRX Health Care
  • LAMR Real Estate
  • Exchange
  • RPRX Nasdaq
  • LAMR Nasdaq
  • Market Cap
  • RPRX 13.9B
  • LAMR 12.1B
  • IPO Year
  • RPRX 2020
  • LAMR 1996
  • Fundamental
  • Price
  • RPRX $33.58
  • LAMR $121.67
  • Analyst Decision
  • RPRX Strong Buy
  • LAMR Buy
  • Analyst Count
  • RPRX 3
  • LAMR 6
  • Target Price
  • RPRX $47.33
  • LAMR $131.83
  • AVG Volume (30 Days)
  • RPRX 5.5M
  • LAMR 505.7K
  • Earning Date
  • RPRX 05-08-2025
  • LAMR 05-08-2025
  • Dividend Yield
  • RPRX 2.62%
  • LAMR 5.05%
  • EPS Growth
  • RPRX 37.60
  • LAMR N/A
  • EPS
  • RPRX 2.45
  • LAMR 4.11
  • Revenue
  • RPRX $2,263,845,000.00
  • LAMR $2,220,416,000.00
  • Revenue This Year
  • RPRX $29.35
  • LAMR $4.83
  • Revenue Next Year
  • RPRX $7.58
  • LAMR $3.71
  • P/E Ratio
  • RPRX $13.70
  • LAMR $29.60
  • Revenue Growth
  • RPRX 1.13
  • LAMR 3.72
  • 52 Week Low
  • RPRX $24.05
  • LAMR $99.84
  • 52 Week High
  • RPRX $34.32
  • LAMR $139.88
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 56.69
  • LAMR 60.87
  • Support Level
  • RPRX $33.37
  • LAMR $119.94
  • Resistance Level
  • RPRX $33.97
  • LAMR $122.59
  • Average True Range (ATR)
  • RPRX 0.53
  • LAMR 2.09
  • MACD
  • RPRX 0.05
  • LAMR 0.13
  • Stochastic Oscillator
  • RPRX 76.06
  • LAMR 90.36

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About LAMR Lamar Advertising Company

Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.

Share on Social Networks: